An Open-Label, Single-Dose, Pharmacokinetic Study of EXE844 Sterile Otic Suspension, 0.3% in Pediatric Subjects Following Tympanostomy Tube Surgery
Phase of Trial: Phase I
Latest Information Update: 11 Aug 2016
At a glance
- Drugs Finafloxacin (Primary)
- Indications Otitis media
- Focus Pharmacokinetics
- Sponsors Alcon
- 19 May 2016 Status changed from recruiting to completed.
- 06 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 May 2016, as reported by ClinicalTrials.gov record.
- 06 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 May 2016, as reported by ClinicalTrials.gov record.